Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 21.30.
Forward PE Ratio (21.30) = Close Price ($229.51) / Consensus Forward EPS ($10.78)
FORWARD PE RATIO
21.30
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+6.95%
vs the sector median at left
Cardinal Health, Inc.
Market Cap
$53.75B
Forward PE Ratio
21.30
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Cardinal Health, Inc. (CAH) | $53.75B | 21.30 |
| Becton, Dickinson and Company (BDX)vs › | $52.90B | 15.15 |
| Edwards Lifesciences Corporation (EW)vs › | $51.70B | 29.92 |
| Moderna, Inc. (MRNA)vs › | $57.59B | N/A |
| Cencora, Inc. (COR)vs › | $61.88B | 17.79 |
| Humana Inc. (HUM)vs › | $45.49B | 41.39 |
| Agilent Technologies, Inc. (A)vs › | $44.89B | 26.24 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.93B | 37.70 |
| IQVIA Holdings Inc. (IQV)vs › | $42.77B | 20.04 |
| DexCom, Inc. (DXCM)vs › | $34.85B | 34.61 |
Trailing P/E
31.7
reported TTM EPS
Forward P/E
21.3
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $10.78 implies +49.1% EPS growth vs the reported trailing $7.23.
At today's $229.51 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-06-30 | $12.54 | $12.13 – $12.65 | 10 | 18.3x |
| 2028-06-30 | $14.09 | $13.36 – $14.32 | 9 | 16.3x |
| 2029-06-30 | $15.65 | $14.31 – $17.53 | 4 | 14.7x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
